01498 PURAPHARM
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 0.47X | Oper Margin | N/A |
|---|---|---|---|
| LT Debt/Equity | 51.4% | Net Margin | N/A |
| Total Debt/Equity | 269.1% | Return on Equity | N/A |
| Price/Book | 1.25X | Return on Assets | N/A |
| (HKD 0.305) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | -35.22 | -35.44 | -106.08 | -120.21 | -121.88 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +0.6 | +66.6 | +11.8 | +1.4 | -484.4 |
| Earnings Per Share (HKD) | -0.084 | -0.09 | -0.269 | -0.305 | -0.31 |
| Earnings Per Share Growth (%) | +6.2 | +66.6 | +11.9 | +1.6 | -462.0 |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
| P/E* (X) | N/A | N/A | N/A | N/A | N/A |
| Yield (%) | N/A | N/A | N/A | N/A | N/A |
| Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
| Book NAV (HKD) | 0.244 | 0.281 | 0.387 | 0.652 | 1.017 |
| Auditors' Opinion | N/A | Unqualified # | Unqualified # | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (HKDMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 336.113 | 382.09 | -12.0 | 406.859 |
| Operating Result | -34.322 | -28.832 | +19.0 | -102.167 |
| Associates | -0.088 | -0.312 | -71.8 | -0.145 |
| Profit Before Taxation | -34.41 | -29.144 | +18.1 | -102.312 |
| Taxation | 0.813 | 6.295 | -87.1 | 3.769 |
| Profit /( Loss) After Taxation | -35.223 | -35.439 | -0.6 | -106.081 |
| Net Profit | -35.223 | -35.439 | -0.6 | -106.081 |
| Earnings Per Share () | -0.0841 | -0.0897 | -6.2 | -0.2685 |
| Announcement Date | 2026-03-26 | 2025-03-31 | NA | 2024-03-28 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
